Abstract
A series of 2-adamantyl-5-arylthiazolyl-1,3,4-oxadiazoles 7a–x together with thiazoles 13 and 14 were synthesized. Compounds 7a–l, 13, and 14 were tested in vitro with the aim of identifying novel lead compounds active against human immunodeficiency virus type-1 and human immunodeficiency virus type-2 activity in MT-4 cells. Title compounds were also tested against representatives of Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Salmonella spp.), various mycobacterial strains (Mycobacterium fortuitum and Mycobacterium smegmatis), yeast (Candida albicans), and mold (Aspergillus fumigatus). None of the compounds showed antiviral or antimicrobial activity, except compounds 13 and 14 exhibited anti-human immunodeficiency virus-1 activity with EC50 values of 1.79 and 2.39 μM with Selectivity index = 18 and 4, respectively. On the other hand, compounds 7a and 7j showed a marked cytotoxicity against the human CD4+ lymphocytes (MT-4). Therefore, 7a and 7j were evaluated for their antiproliferative activity against two solid tumor-derived cell lines, which exhibited IC50 values of 8.1 ± 0.10 µM and 4.8 ± 0.08 µM against Hep-G2 cell lines, respectively.
Similar content being viewed by others
References
Ahgren C, Backro K, Bell FB, Cantrell AS, Clemens M, Colacino J, Deeter MJB, Engelhardt JA, Jaskunas SR (1995) The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 39:1329–1335
Akhtar T, Hameed S, Al-Masoudi NA, Loddo R, La Colla P (2008) In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione. Acta Pharm (Weinheim) 58:135–149
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo LG, Schoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601
Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1993) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
Baxter A, Bent J, Bowers K, Braddock M, Brough S, Fagura, Lawson M, McInally T, Mortimore M, Robertson M, Weaver R, Webborn P (2003) Hit-to-lead studies: the discovery of potent adamantine amide P2X7 receptor antagonists. Bioorg Med Chem Lett 13:4047–4050
Bell FW, Cantrell AS, Hoegberg M, Jaskunas SR, Johansson NG, Jordan CL, Kinnick MD, Lind P, Morin Jr JM, Noreen R, Oberg B, Palkowitz JA, Parrish CA, Pranc P, Sahlberg C, Ternansky RJ, Vasileff RT, Vrang L, West SJ, Zhang H, Zhou X-X (1995) Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-ctivity relationship studies of PETT analogs. J Med Chem 38:4929–4936
Cai Z-Q, Liu J, Wang Y, Zhang M-R, Chen Y, Xu L-F, Gong M (2014) A cup-like structure: synthesis, crystal structure and anti-cancer activity of 2-(2-(4,5-diphenyl-1H-imidazol-1-yl)acetamido)ethyl adamantane-1-carboxylate. J Chem Soc Pak 36:717–722
Cantrell AS, Engelhardt P, Hogberg M, Jaskunas SR, Johansson NG, Jordan CL, Kangasmetsä J, Kinnick MD, Lind P, Morin Jr JM, Muesing MA, Noreén R, Öberg B, Pranc P, Sahlberg C, Ternansky RJ, Vasileff RT, Vrang L, West SJ, Zhang H (1996) Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure–activity relationship studies of PETT analogs. J Med Chem 39:4261–4274
Dawood KM, Eldebss TMA, El-Zahabi HSA, Yousef MH, Metz P (2013) Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents. Eur J Med Chem 70:740–749
D’Cruz OJ, Samuel P, Uckun FM (2004) PHI-443: a novel noncontraceptive broad spectrum anti-human immunodeficiency virus microbicide. Biolo Reprod 71:2037–2047
D’Cruz OJ (2006) Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J Antimicrob Chemother 57:411–423
De Clercq E (2009) Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 33:307–320
de Souza MVN, Bispo MLF, Gonçalves RSB, Kaiser CR (2011) Thiourea derivatives: A promising class against HIV/TB co-infection. Global View of HIV Infection, Dr. Venketaraman V (Ed.), InTech, 127–161
Dodson RM, King LC (1945) The reaction of ketones with halogens and thiourea. J Am Chem Soc 67:2242–2243
Hargrave KD, Proudfoot JR, Grozinger KG, Cullen E, Kapadia SR, Patel UR, Fuchs VU, Mauldin SC, Vitous J, Behnke ML, Klunder JM, Pal K, Skiles JW, McNeil DW, Rose JM, Chow GC, Skoog MT, Wu JC, Schmidt G, Engel WW, Eberlein WG, Saboe TD, Campbell SJ, Rosenthal AS, Adams J (1991) Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. J Med Chem 34:2231–2241
Heinisch G, Matuszczak B, Pachler S, Rakowitz B (1997) The inhibitory activity of diazinyl-substituted thiourea derivatives on human immunodeficiency virus type 1 reverse transcriptase. Antivir Chem Chemother 8:443–446
Imamichi T (2004) Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors. Curr Pharm Des 10:4039–4053
Jonckheere H, Anne J, De Clercq E (2000) The HIV-1 reverse transcription (RT) process a target for RT inhibitors. Med Res Rev 20:129–154
Kabbani AT, Ramadan H, Hammud HH, Ghannoum AM, Mouneimne YJ (2005) Synthesis of some metal complexes of N-(benzoylamino)-thioxomethyl]amino acid (HL). Uni Chem Techn Metal 40:339–344
Khan MH, Akhtar T, Yasin KA, Al-Masoudi NA, Jones PG, Hameed S (2010) Synthesis, crystal structure and biological evaluation of 6-adamantyl-3-aryl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Z Naturforsch 65b:178–184
Khan MH, Akhtar T, Al-Masoudi NA, Stoeckli-Evans H, Hameed S (2012) Synthesis, crystal structure and anti-HIV activity of 2-adamantyl/adamantylmethyl-5-aryl-1,3,4-oxadiazoles. Med Chem 8:1190–1197
Khan MH, Hameed S, Farman M, Al- Masoudi NA, Stoeckli-Evans H (2015) Synthesis, anti HIV and molecular modeling study of 3-aryl-6-adamantyl-methyl-[1,2,4-]triazolo[3,4-b]thiazdiazole derivatives. Z Naturforsch 70b:609–616
Maynard M, Pradat P, Bailly F, Rozier F, Nemoz C, Ahmed SN, Adeliene P, Trepo C (2006) Amantadine triple therapy for non-responder hepatitis C patients: clues for controversies (ANRS HC 03 BITRI). J Hepato 44:484–490
Mishra CB, Kumari S, Tiwari M (2015) Thiazole: a promising heterocycle for the development of potent CNS active agents. Eur J Med Chem 92:1–34
Miyoshi I, Taguchi H, Kobonishi I, Yoshimoto S, Ohtsuki Y, Shiraishi Y, Akagi T (1982) Type C virus-producing cell lines derived from adult T cell leukemia. Gann Monogr Canc Res 28:219–228
Pannecouque C, Daelemans D, De Clercq E (2008) Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited, 20 years later. Nat Protoc 3:427–434
Pauwles R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20:309–321
Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
Ren J, Diprose J, Warren J, Esnouf RM, Bird LE, Ikemizu S, Slater M, Milton J, Balzarini J, Stuart DI, Stammers DK (2000) Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases: structural and biochemical analysis. J Biol Chem 275:5633–5639
Uckun FM, Venkatachalam TK (2005) Adamantyl thiazole thioureas, United States Patent 005, 6960606
Uyeki EM, Nishio A, Wittek PJ, Cheng CC (1981) Antiproliferative activity of doxorubicin and aminoanthraquinone derivatives on chinese hamster ovary cell. J Pharm Sci 70:1011–1014
Vicini P, Incerti M, Doytchinova IA, La Colla P, Busonera B, Loddo R (2006) Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones. Eur J Med Chem 41:624–632
Wainberg MA, Sawyer JP, Montaner JS, Murphy RL, Kuritzkes DR, Raffi F (2005) Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. Antiviral Ther 10:13–28
Willker W, Leibfritz D, Kerssebaum R, Bermel W (1993) Gradient selection in inverse heteronuclear correlation spectroscopy. Magn Reson Chem 31:287–292
Xu Z, Ba M, Zhou H, Cao Y, Tang C, Yang Y, He R, Liang Y, Zhang Z, Li Z, Zhu L, Guo Y, Guo C (2014) 2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase. Eur J Med Chem 85:27–42
Yu J, Liu H, Xia G, Liu L, Xu Z, Chen Q, Ma C, Sun X, Xu J, Li H, Li P, Shi Y, Xiong B, Liu X, Shen J (2013) Discovery of 2-alkyl-1-arylsulfonylprolinamides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors. ACS Med Chem Lett 3:793–798
Zahid M, Yasin KA, Akhtar T, Rama NH, Hameed S, Al-Masoudi NA, Loddo R, La Colla P (2009) New 2-(4-aryl)-5-(2-adamantylthiazol-4-yl)-1,3,4-oxadiazoles as potential antiproliferative and antiviral agents. Arkivoc xi:85–93
Zia M, Akhtar T, Hameed S, Al-Masoudi NA (2012) New aryl-1,3-thiazole-4-carbohydr-azides, their 1,3,4-oxadiazole-2-thione-1,2,4-triazole, isatin-3-ylidene and carboxamide derivatives: synthesis and anti-HIV activity. Z Naturforsch 67b:747–758
Acknowledgments
This work was financially supported by Higher Education Commission (HEC) of Pakistan through a Ph.D. fellowship to Mahmood-ul-Hassan Khan under “Indigenous Ph.D 5000 Fellowship Program”. Miss A. Friemel of the Chemistry Department, University of Konstanz, Germany, is highly acknowledged for the NMR experiments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Najim A. Al-Masoudi’s present address: Am Tannenhof 8, 78464 Konstanz, Germany
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Khan, MuH., Hameed, S., Akhtar, T. et al. Synthesis, crystal structure, anti-HIV, and antiproliferative activity of new oxadiazole and thiazole analogs. Med Chem Res 25, 2399–2409 (2016). https://doi.org/10.1007/s00044-016-1669-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1669-9